A murine model of obesity with accelerated atherosclerosis.
about
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesRabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicineMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient miceMouse models of the metabolic syndrome.Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue.Effects of intra-abdominal sepsis on atherosclerosis in miceVSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet.Thrombospondin1 deficiency attenuates obesity-associated microvascular complications in ApoE-/- miceThe small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetesAnalysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease.Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesEndogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice.dFatp regulates nutrient distribution and long-term physiology in DrosophilaSerum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes.High-density lipoprotein and the acute phase response.Drosophila models of cardiac disease.Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus.Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosisCombination benefit of amlodipine plus atorvastatin treatment on carotid atherosclerosis in Zucker metabolic rats.
P2860
Q26822630-322A6FD8-99B9-4FAA-A1E0-609240138C83Q26853133-FD534886-DB81-45FE-9687-BB9A2E9D2A3CQ28070313-7F732A04-CA53-471A-B16A-5EC7AC77864FQ28302517-871BAEC6-0BEA-4978-BA8B-45773B418924Q33849244-9DE69484-6E9E-445A-9818-6BBBC23AFC41Q33911023-A861F5BB-EB9C-437D-A20C-4AE6EB1685ADQ34234151-9FE4B936-73FA-49CF-8955-E8F141D28464Q34428997-55E92EBB-6434-405F-9CAD-0521A20173F4Q34586914-FD7809AB-F931-4CB4-A5C9-3A0F9B8C9ABBQ35214311-520005B8-9C30-4631-B979-D562A894A2A2Q35905949-C360CDEE-7CCA-4B8C-A817-800184BC9877Q36087475-F9440C94-77C6-4B05-BBB5-2564AA69F64BQ36175435-62D8BAD1-6339-489D-8255-91BDEC9E8A4AQ36353275-3FA3B435-BEDF-4EF1-8B3D-DC8557F7312CQ36498682-B438CFAD-C235-4DE2-A333-7172EDFC8551Q36962846-F65604B6-4097-488A-9DAB-2B02BAF543A2Q37696936-E597DFEB-DF66-4039-B275-B2B42EE46021Q37850142-2F402B0F-56B9-4CC4-B2CC-E2D2C4AD0EE8Q40289404-54A3FDE7-BCB0-4393-8E87-5157F1243C74Q41870298-D6BA4314-4A60-4F81-9AA9-F1D89ED8E04AQ44899933-3503865F-5FDF-43DD-B9E3-06FE907D28F6
P2860
A murine model of obesity with accelerated atherosclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A murine model of obesity with accelerated atherosclerosis.
@ast
A murine model of obesity with accelerated atherosclerosis.
@en
type
label
A murine model of obesity with accelerated atherosclerosis.
@ast
A murine model of obesity with accelerated atherosclerosis.
@en
prefLabel
A murine model of obesity with accelerated atherosclerosis.
@ast
A murine model of obesity with accelerated atherosclerosis.
@en
P2093
P2860
P356
P1433
P1476
A murine model of obesity with accelerated atherosclerosis.
@en
P2093
Frederick C de Beer
Huei-Wei Chan
Lisa R Tannock
Marcielle C de Beer
Victoria L King
P2860
P356
10.1038/OBY.2009.176
P577
2009-06-04T00:00:00Z